CMMB vs PSX · $22.2M cap vs P/E 17, rev $83.54B
Chemomab Therapeutics Ltd DRC (CMMB) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
CMMB does not have a complete income-statement cache yet.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
CMMB currently screens at market cap $22.2M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the CMMB and PSX stock pages for the full models.
Not investment advice.